Orexigen Therapeutics, Inc. 4
4 · Orexigen Therapeutics, Inc. · Filed Jul 14, 2016
Insider Transaction Report
Form 4
Moglia Stephen A.
VP, Chief Accounting Officer
Transactions
- Award
Stock Option
2016-07-12+28,800→ 28,800 totalExercise: $15.00Exp: 2026-07-11→ Common Stock (28,800 underlying) - Award
Stock Option
2016-07-12+48,000→ 48,000 totalExercise: $4.02Exp: 2026-07-11→ Common Stock (48,000 underlying)
Footnotes (2)
- [F1]Thirty-three and one-third percent (33-1/3%) of the shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the one year anniversary of 07/12/2016, and 1/36 of the shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each month thereafter, so that all of the shares of the stock subject to the option shall be vested on the third (3rd) anniversary of 07/12/2016, subject to the employee's continued service relationship (whether as an employee, director or consultant) with the Corporation or any parent or subsidiary on each such date, as set forth in the applicable stock option grant notice and stock option agreement for such employee.
- [F2]Not Applicable